Retinal Vein Occlusion Amongst People Vaccinated by mRNA- and Viral Vector- COVID-19 Vaccines: A Systematic Review

References

• Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–160. doi:10.23750/abm.v91i1.9397
   PubMedGoogle Scholar
• Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Adriana DN, Miftahussurur M. Current strategy to combat COVID-19 in Indonesia. New Armen Med J. 2020;14(4):16–28.
   Web of Science ®Google Scholar
• Xie M, Chen Q. Insight into 2019 novel coronavirus — an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020;94:119–124. doi:10.1016/j.ijid.2020.03.071
   PubMed Web of Science ®Google Scholar
• Lu H, Stratton CW, Tang Y. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi:10.1002/jmv.25678
   PubMed Web of Science ®Google Scholar
• Triyono EA, Seipalla F, Djaja N, et al. Clinical characteristics of patients with COVID-19 admitted to the COVID-19 emergency field hospital of Bangkalan, Indonesia. F1000Research. 2022;11:414. doi:10.12688/f1000research.110716.2
   PubMedGoogle Scholar
• Soedarsono S, Semedi BP, Setiawati R, et al. Case report: survival of a coronavirus disease-2019 (Covid-19) patient with Acute Respiratory Distress Syndrome (ARDS) in Dr. Soetomo Hospital, Surabaya, Indonesia. Folia Med. 2021;56(3):235. doi:10.20473/fmi.v56i3.24584
   Google Scholar
• Haryati H, Isa M, Assagaf A, Nurrasyidah I, Kusumawardhani E. Clinical characteristics of hospitalized individuals dying with COVID-19 in Ulin Regional Hospital Banjarmasin. J Respirasi. 2021;7(1):1. doi:10.20473/jr.v7-I.1.2021.1-7
   Google Scholar
• Centers for Disease Control and Prevention. How COVID-19 Spreads. Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html?. Accessed January 13, 2023.
   Google Scholar
• Yamani LN, Syahrul F. Public health perspective of the COVID‑19 pandemic: host characteristics and prevention of COVID-19 in the community (Review). World Acad Sci J. 2020;2(6). doi:10.3892/wasj.2020.62
   Google Scholar
• World Health Organization. COVID-19 vaccines with WHO emergency use listing. Vaccines; 2023. Available from: https://extranet.who.int/pqweb/vaccines/vaccinescovid-19-vaccine-eul-issued. Accessed January 13, 2023.
   Google Scholar
• Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020;288:198114. doi:10.1016/j.virusres.2020.198114
   PubMed Web of Science ®Google Scholar
• World Health Organization. 11 vaccines granted emergency use listing (EUL) by WHO. COVID 19 vaccine tracker; 2023. Available from: https://covid19.trackvaccines.org/agency/who/. Accessed March 19, 2023.
   Google Scholar
• Arbel R, Hammerman A, Sergienko R, et al. BNT162b2 vaccine booster and mortality due to Covid-19. N Engl J Med. 2021;385(26):2413–2420. doi:10.1056/NEJMoa2115624
   PubMed Web of Science ®Google Scholar
• Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1216–1224. doi:10.1080/09273948.2021.1976221
   PubMed Web of Science ®Google Scholar
• Kumari S, Anand R, Sambyal B, Singh Y. Ocular adverse effects of COVID-19 vaccines: a systematic review. J Family Med Prim Care. 2022;11(9):5041 doi:10.4103/jfmpc.jfmpc_747_22.
   PubMedGoogle Scholar
• Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol. 2010;809. doi:10.2147/OPTH.S7631
   PubMedGoogle Scholar
• Feltgen N, Ach T, Ziemssen F, et al. Retinal vascular occlusion after COVID-19 vaccination: more coincidence than causal relationship? Data from a retrospective multicentre study. J Clin Med. 2022;11(17):5101. doi:10.3390/jcm11175101
   PubMed Web of Science ®Google Scholar
• Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   Google Scholar
• Shah VA, Randolph J, Hsu J, Gurnani B, Lim JI, Marcet MM. Retinal vein occlusion. EyeWiki; 2022. Available from: https://eyewiki.aao.org/Retinal_Vein_Occlusion. Accessed January 15, 2023.
   Google Scholar
• Moola S, Munn Z, Tufanaru C, et al. Systematic reviews of etiology and risk. In: editors, Aromataris E, Munn Z. JBI Manual for Evidence Synthesis. JBI; 2020. doi:10.46658/JBIMES-20-01
   Google Scholar
• Rachman MJ, Kalanjati VP, Khadijah F, Nasution MHF. Retinal vein occlusion amongst people vaccinated by COVID-19 mRNA- and viral vector-vaccines: a systematic review. Prospero. 2023. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023393304. Accessed September 19, 2023.
   Google Scholar
• Al-Abri M, Al-Musalami A, Al-Rawahi B, Al-Hinai A, Al-Fadhil N. Central retinal vein occlusion in a young healthy COVID-19 patient: a case report and literature review. Middle East Afr J Ophthalmol. 2021;28(3):199. doi:10.4103/meajo.meajo_271_21
   PubMed Web of Science ®Google Scholar
• Bialasiewicz AA, Farah-Diab MS, Mebarki HT. Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine. Int Ophthalmol. 2021;41(12):3889–3892. doi:10.1007/s10792-021-01971-2
   PubMed Web of Science ®Google Scholar
• Endo B, Bahamon S, Martínez-Pulgarín D. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: a case report. Indian J Ophthalmol. 2021;69(10):2865. doi:10.4103/ijo.IJO_1477_21
   PubMed Web of Science ®Google Scholar
• Goyal M, Murthy S, Srinivas Y. Unilateral retinal vein occlusion in a young, healthy male following Sputnik V vaccination. Indian J Ophthalmol. 2021;69(12):3793. doi:10.4103/ijo.IJO_2412_21
   PubMed Web of Science ®Google Scholar
• Ikegami Y, Numaga J, Okano N, Fukuda S, Yamamoto H, Terada Y. Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination. QJM an Int J Med. 2021;114(12):884–885. doi:10.1093/qjmed/hcab287
   Web of Science ®Google Scholar
• Tanaka H, Nagasato D, Nakakura S, et al. Exacerbation of branch retinal vein occlusion post SARS-CoV2 vaccination. Medicine (Baltimore). 2021;100(50):e28236. doi:10.1097/MD.0000000000028236
   PubMed Web of Science ®Google Scholar
• Cackett P, Ali A, Young SL. Phenotypic appearance of central retinal vein occlusion post AstraZeneca vaccine. Int J Ophthalmol. 2022;15(4):672–673. doi:10.18240/ijo.2022.04.24
   PubMed Web of Science ®Google Scholar
• Chen YC. Combined central retinal artery occlusion and vein occlusion with exudative retinal detachment following COVID ‐19 vaccination. Kaohsiung J Med Sci. 2022;38(10):1020–1021. doi:10.1002/kjm2.12591
   PubMed Web of Science ®Google Scholar
• Dutta Majumder P, Prakash V. Retinal venous occlusion following COVID-19 vaccination: report of a case after third dose and review of the literature. Indian J Ophthalmol. 2022;70(6):2191. doi:10.4103/ijo.IJO_592_22
   PubMed Web of Science ®Google Scholar
• Fernández-Vigo JI, Perálvarez Conde C, Burgos-Blasco B, Fernández-Vigo JA. Bilateral retinal vein occlusion after two doses of SARS-CoV-2 adenovirus vector-based vaccine. J Fr Ophtalmol. 2022;45(9):e397–e399. doi:10.1016/j.jfo.2022.05.006
   PubMed Web of Science ®Google Scholar
• Karageorgiou G, Chronopoulou K, Georgalas I, Kandarakis S, Tservakis I, Petrou P. Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. Eur J Ophthalmol. 2023;33(5):NP121–3. doi:10.1177/11206721221124651
   PubMed Web of Science ®Google Scholar
• Lee S, Sankhala KK, Bose S, Gallemore RP. Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination. Int Med Case Rep J. 2022;15:7–14. doi:10.2147/IMCRJ.S328931
   PubMed Web of Science ®Google Scholar
• Noguchi K, Takahashi R, Makino S. Central retinal vein occlusion following mRNA severe acute respiratory syndrome coronavirus 2 vaccination. Int J Case Rep Images. 2022;13(2):105–107. doi:10.5348/101337Z01KN2022CI
   Google Scholar
• Parakh S, Maheshwari S, Das S, et al. Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination – can it be explained by the two-hit hypothesis? J Ophthalmic Inflamm Infect. 2022;12(1):34. doi:10.1186/s12348-022-00311-4
   PubMed Web of Science ®Google Scholar
• Priluck AZ, Arevalo JF, Pandit RR. Ischemic retinal events after COVID-19 vaccination. Am J Ophthalmol Case Rep. 2022;26:101540. doi:10.1016/j.ajoc.2022.101540
   PubMedGoogle Scholar
• Pur DR, Bursztyn LLCD, Iordanous Y. Branch retinal vein occlusion in a healthy young man following mRNA COVID-19 vaccination. Am J Ophthalmol Case Rep. 2022;26:101445. doi:10.1016/j.ajoc.2022.101445
   PubMedGoogle Scholar
• Romano D, Morescalchi F, Romano V, Semeraro F. COVID-19 AdenoviralVector vaccine and central retinal vein occlusion. Ocul Immunol Inflamm. 2022;30(5):1286–1288. doi:10.1080/09273948.2022.2079534
   PubMed Web of Science ®Google Scholar
• Ruiz OAG, González-López JJ. Simultaneous unilateral central retinal vein occlusion and branch retinal artery occlusion after Coronavirus disease 2019 (COVID-19) mRNA vaccine. Arq Bras Oftalmol. 2022;87(2). doi:10.5935/0004-2749.2022-0010
   Google Scholar
• Sacconi R, Simona F, Forte P, Querques G. Retinal vein occlusion following two doses of mRNA-1237 (Moderna) immunization for SARS-Cov-2: a case report. Ophthalmol Ther. 2022;11(1):453–458. doi:10.1007/s40123-021-00441-3
   PubMed Web of Science ®Google Scholar
• Sodhi PK, Yadav A, Sharma B, Sharma A, Kumar P. Central retinal vein occlusion following the first dose of COVID vaccine. Cureus. 2022;14(6). doi:10.7759/cureus.25842
   Web of Science ®Google Scholar
• Sonawane NJ, Yadav D, Kota AR, Singh HV, Panigrahi PK. Central retinal vein occlusion post-COVID-19 vaccination. Indian J Ophthalmol. 2022;70(5):308–309. doi:10.4103/ijo.IJO_1757_21
   PubMed Web of Science ®Google Scholar
• Sugihara K, Kono M, Tanito M. Branch retinal vein occlusion after messenger RNA-based COVID-19 vaccine. Case Rep Ophthalmol. 2022;13(1):28–32. doi:10.1159/000521838
   PubMed Web of Science ®Google Scholar
• Takacs A, Ecsedy M, Nagy ZZ. Possible COVID-19 MRNA vaccine-induced case of unilateral central retinal vein occlusion. Ocul Immunol Inflamm. 2022;1–6. doi:10.1080/09273948.2022.2094811
   Web of Science ®Google Scholar
• Tanaka H, Nagasato D, Nakakura S, et al. Branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination. Taiwan J Ophthalmol. 2022;12(2):202. doi:10.4103/tjo.tjo_24_22
   PubMedGoogle Scholar
• Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. 2021;10(24):5960. doi:10.3390/jcm10245960
   PubMed Web of Science ®Google Scholar
• Girbardt C, Busch C, Al-Sheikh M, et al. Retinal vascular events after mRNA and adenoviral-vectored COVID-19 vaccines—A case series. Vaccines. 2021;9(11):1349. doi:10.3390/vaccines9111349
   Web of Science ®Google Scholar
• Park HS, Byun Y, Byeon SH, Kim SS, Kim YJ, Lee CS. Retinal hemorrhage after SARS-CoV-2 vaccination. J Clin Med. 2021;10(23):5705. doi:10.3390/jcm10235705
   PubMed Web of Science ®Google Scholar
• da Silva LSC, Finamor LPS, Andrade GC, et al. Vascular retinal findings after COVID-19 vaccination in 11 cases: a coincidence or consequence? Arq Bras Oftalmol. 2022;85(2). doi:10.5935/0004-2749.20220071
   Web of Science ®Google Scholar
• Choi M, Seo MH, Choi KE, et al. Vision-threatening ocular adverse events after vaccination against coronavirus Disease 2019. J Clin Med. 2022;11(12):3318. doi:10.3390/jcm11123318
   PubMed Web of Science ®Google Scholar
• Peters MC, Cheng SSH, Sharma A, Moloney TP. Retinal vein occlusion following COVID ‐19 vaccination. Clin Experiment Ophthalmol. 2022;50(4):459–461. doi:10.1111/ceo.14056
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Limoli C, Romano S, Vitale L, Villani E, Nucci P. Retinal vascular occlusion and SARS-CoV-2 vaccination. Graefe’s Arch Clin Exp Ophthalmol. 2022;260(11):3455–3464. doi:10.1007/s00417-022-05707-5
   PubMed Web of Science ®Google Scholar
• Jampol LM, Tauscher R, Schwarz HP. COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina. JAMA Ophthalmol. 2021;139(10):1135. doi:10.1001/jamaophthalmol.2021.3483
   PubMed Web of Science ®Google Scholar
• Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981;1(1):27–55.
   PubMedGoogle Scholar
• Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100(7):1132–1140. doi:10.1001/archopht.1982.01030040110020
   PubMedGoogle Scholar
• Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:1–5. doi:10.1155/2014/724780
   Web of Science ®Google Scholar
• Leung HM, Au SCL. Retinal vein occlusion after COVID-19 vaccination—A review. Vaccines. 2023;11(8):1281. doi:10.3390/vaccines11081281
   Web of Science ®Google Scholar
• Almehdi AM, Khoder G, Alchakee AS, Alsayyid AT, Sarg NH, Soliman SSM. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection. 2021;49(5):855–876. doi:10.1007/s15010-021-01677-8
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi:10.1056/NEJMoa2104840
   PubMed Web of Science ®Google Scholar
• Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384(22):2124–2130. doi:10.1056/NEJMoa2104882
   PubMed Web of Science ®Google Scholar
• Dodson PM, Kubicki AJ, Taylor KG, Kritzinger EE. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophthalmol. 1985;69(7):493–496. doi:10.1136/bjo.69.7.493
   PubMed Web of Science ®Google Scholar
• Ullah I, Sohail A, Shah MUFA, et al. Central retinal vein occlusion in patients with COVID-19 infection: a systematic review. Ann Med Surg. 2021;71:102898. doi:10.1016/j.amsu.2021.102898
   PubMed Web of Science ®Google Scholar
• Dorney I, Shaia J, Kaelber DC, Talcott KE, Singh RP. Risk of new retinal vascular occlusion after mRNA COVID-19 vaccination within aggregated electronic health record data. JAMA Ophthalmol. 2023;141(5):441. doi:10.1001/jamaophthalmol.2023.0610
   PubMed Web of Science ®Google Scholar
• Au CL. Prevalence of SARS-CoV-2 among central retinal vein occlusion patients. Indian J Ophthalmol. 2021;69(5):1355. doi:10.4103/ijo.IJO_88_21
   PubMed Web of Science ®Google Scholar
• Gupta AK, Lahiri KD. Subclinical hypothyroidism: a modifiable risk factor for retinal vein occlusion. J Clin Diagn Res. 2021;15(4). doi:10.7860/JCDR/2021/47113.14793
   Web of Science ®Google Scholar
• Madanagopalan VG, Paneer Selvam V, Sarath Sivan NV, Govindaraju NV. Central retinal vein occlusion in a patient with breast carcinoma. GMS Ophthalmol Cases. 2019;9:Doc04. doi:10.3205/oc000093
   PubMedGoogle Scholar
• Castro-Navarro V, Odaibo SG, Ghodasra DH, Besirli CG. Bilateral BRVO in a patient with recurrent prostate cancer. BMJ Case Rep. 2015;bcr2015212463. doi:10.1136/bcr-2015-212463
   PubMedGoogle Scholar
• Thomas RH. Hypercoagulability syndromes. Arch Intern Med. 2001;161(20):2433–2439. doi:10.1001/archinte.161.20.2433
   PubMedGoogle Scholar
• Toft-Petersen AP, Muttuvelu DV, Heegaard S, Torp-Pedersen C. Correlation between retinal vein occlusion and cancer - a nationwide Danish cohort study. Acta Ophthalmol. 2018;96(8):800–803. doi:10.1111/aos.13860
   PubMed Web of Science ®Google Scholar
• Lee CS, Lee ML, Gibbons LE, et al. Associations between retinal artery/vein occlusions and risk of vascular dementia. J Alzheimer’s Dis. 2021;81(1):245–253. doi:10.3233/JAD-201492
   PubMed Web of Science ®Google Scholar
• Li X, Burn E, Duarte-Salles T, et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022:e071594. doi:10.1136/bmj-2022-071594
   PubMedGoogle Scholar
• Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27(7):1290–1297. doi:10.1038/s41591-021-01408-4
   PubMed Web of Science ®Google Scholar
• Simpson CR, Kerr S, Katikireddi SV, et al. Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Commun. 2022;13(1):4800. doi:10.1038/s41467-022-32264-6
   PubMed Web of Science ®Google Scholar
• Li JX, Wang YH, Bair H, et al. Risk assessment of retinal vascular occlusion after COVID-19 vaccination. NPJ Vaccines. 2023;8(1):64. doi:10.1038/s41541-023-00661-7
   PubMed Web of Science ®Google Scholar
• Smadja DM, Yue QY, Chocron R, Sanchez O, Lillo-le Louet A. Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. Eur Respir J. 2021;58(1):2100956. doi:10.1183/13993003.00956-2021
   PubMed Web of Science ®Google Scholar
• Singh RB, Parmar UPS, Gupta R, et al. Retinal vascular occlusion following SARS-CoV-2 vaccination: a VAERS database analysis. Ophthalmol Sci. 2023:100354. doi:10.1016/j.xops.2023.100354
   PubMedGoogle Scholar
• World Health Organization. Approved vaccines. COVID 19 Vaccine tracker; 2023. Available from: https://covid19.trackvaccines.org/vaccines/approved/. Accessed August 17, 2023.
   Google Scholar
• Lam WY, Au SCL. Big data are needed for analysis of the association of retinal vascular occlusion and COVID-19. Graefe’s Arch Clin Exp Ophthalmol. 2023;261(9):2717–2718. doi:10.1007/s00417-023-06043-y
   PubMedGoogle Scholar